This image was lost some time after publication.

When we revealed recently that Pfizer had put two of its corporate jets up for sale, we assumed it was a cost-cutting measure on the pharma conglomerate's part. It may be. But not necessarily! David Collins of the Connecticut newspaper The Day attempted to get to the bottom of things last week and was initially told by a press rep that the company was selling the planes as a "function of cost reduction initiatives." A couple of days later, though, Pfizer reversed course, informing Collins that the company would evaluate its options "for replacing these vehicles." So if you were concerned about poor Jeff Kindler having to deal with the indignity of commercial air travel, guess you needn't give up hope just yet. [The Day, previously]